Alberto D'Angelo

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Venues

PloS one

Cancers

Diseases (Basel, Switzerland)

International journal of molecular sciences

University of Bath

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bath Oct 01 2018

United Kingdom

PhD Student :: Biochemistry

Publications

Simona Laurino, Sabino Russi, Ludmila Carmen Omer, Alberto D'Angelo, Giovanni Bozza, Giuseppina Gallucci, Geppino Falco, Giandomenico Roviello, Anna Maria Bochicchio
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. Diseases (Basel, Switzerland) 12 (3) (2024)
Simona Laurino, Sabino Russi, Ludmila Carmen Omer, Alberto D'Angelo, Giovanni Bozza, Giuseppina Gallucci, Geppino Falco, Giandomenico Roviello, Anna Maria Bochicchio
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. Diseases (Basel, Switzerland) 12 (3) (2024)
Simona Laurino, Sabino Russi, Ludmila Carmen Omer, Alberto D'Angelo, Giovanni Bozza, Giuseppina Gallucci, Geppino Falco, Giandomenico Roviello, Anna Maria Bochicchio
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. Diseases (Basel, Switzerland) 12 (3) (2024)
Alberto D'Angelo, Martina Catalano, Raffaele Conca, Roberto Petrioli, Francesca Siminonato, Alessandro Cappetta, Giandomenico Roviello, Monica Ramello
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine. Journal of chemotherapy (Florence, Italy) (2023)
Marianna Sirico, Alberto D'Angelo, Caterina Gianni, Chiara Casadei, Filippo Merloni, Ugo De Giorgi
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy. Cancers 15 (3) (2023)
Marianna Sirico, Alberto D'Angelo, Caterina Gianni, Chiara Casadei, Filippo Merloni, Ugo De Giorgi
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy. Cancers 15 (3) (2023)
Alberto D'Angelo, Huseyin Kilili, Robert Chapman, Daniele Generali, Ingeborg Tinhofer, Stefano Luminari, Benedetta Donati, Alessia Ciarrocchi, Riccardo Giannini, Roberto Moretto, Chiara Cremolini, Filippo Pietrantonio, Navid Sobhani, Deborah Bonazza, Robert Prins, Seung Geun Song, Yoon Kyung Jeon, Giuseppina Pisignano, Mattia Cinelli, Stefan Bagby, Araxi O Urrutia
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses. PloS one 18 (1) (2023)
Alberto D'Angelo, Huseyin Kilili, Robert Chapman, Daniele Generali, Ingeborg Tinhofer, Stefano Luminari, Benedetta Donati, Alessia Ciarrocchi, Riccardo Giannini, Roberto Moretto, Chiara Cremolini, Filippo Pietrantonio, Navid Sobhani, Deborah Bonazza, Robert Prins, Seung Geun Song, Yoon Kyung Jeon, Giuseppina Pisignano, Mattia Cinelli, Stefan Bagby, Araxi O Urrutia
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses. PloS one 18 (1) (2023)
Alberto D'Angelo, Huseyin Kilili, Robert Chapman, Daniele Generali, Ingeborg Tinhofer, Stefano Luminari, Benedetta Donati, Alessia Ciarrocchi, Riccardo Giannini, Roberto Moretto, Chiara Cremolini, Filippo Pietrantonio, Navid Sobhani, Deborah Bonazza, Robert Prins, Seung Geun Song, Yoon Kyung Jeon, Giuseppina Pisignano, Mattia Cinelli, Stefan Bagby, Araxi O Urrutia
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses. PloS one 18 (1) (2023)
Alberto D'Angelo, Huseyin Kilili, Robert Chapman, Daniele Generali, Ingeborg Tinhofer, Stefano Luminari, Benedetta Donati, Alessia Ciarrocchi, Riccardo Giannini, Roberto Moretto, Chiara Cremolini, Filippo Pietrantonio, Navid Sobhani, Deborah Bonazza, Robert Prins, Seung Geun Song, Yoon Kyung Jeon, Giuseppina Pisignano, Mattia Cinelli, Stefan Bagby, Araxi O Urrutia
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses. PloS one 18 (1) (2023)
Alberto D'Angelo, Huseyin Kilili, Robert Chapman, Daniele Generali, Ingeborg Tinhofer, Stefano Luminari, Benedetta Donati, Alessia Ciarrocchi, Riccardo Giannini, Roberto Moretto, Chiara Cremolini, Filippo Pietrantonio, Navid Sobhani, Deborah Bonazza, Robert Prins, Seung Geun Song, Yoon Kyung Jeon, Giuseppina Pisignano, Mattia Cinelli, Stefan Bagby, Araxi O Urrutia
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses. PloS one 18 (1) (2023)
Alberto D'Angelo, Fabiola Giudici, Robert Chapman, Jacob Darlow, Huseyin Kilili, Navid Sobhani, Mattia Cinelli, Maria Rosa Cappelletti, Carla Strina, Manuela Milani, Daniele Generali
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study. Current issues in molecular biology 44 (9) (2022)
Navid Sobhani, Richard Chahwan, Raheleh Roudi, Rachel Morris, Stefano Volinia, Dafei Chai, Alberto D'Angelo, Daniele Generali
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer. Cancers 14 (12) (2022)
Alberto D'Angelo, Robert Chapman, Marianna Sirico, Navid Sobhani, Martina Catalano, Enrico Mini, Giandomenico Roviello
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next. Cancer chemotherapy and pharmacology 90 (3) (2022)
Navid Sobhani, Praveen Kumar Neeli, Alberto D'Angelo, Matteo Pittacolo, Marianna Sirico, Ilaria Camilla Galli, Giandomenico Roviello, Gabriella Nesi
AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption. International journal of molecular sciences 22 (11) (2021)
Giandomenico Roviello, Silvia Paola Corona, Alberto D'Angelo, Pietro Rosellini, Stefania Nobili, Enrico Mini
Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis. International journal of molecular sciences 21 (2) (2020)
Alberto D'Angelo, Navid Sobhani, Stefan Bagby, Andrea Casadei-Gardini, Giandomenico Roviello
Cabozantinib as a second-line treatment option in hepatocellular carcinoma. Expert review of clinical pharmacology 13 (6) (2020)
Navid Sobhani, Alberto D'Angelo, Xu Wang, Ken H Young, Daniele Generali, Yong Li
Mutant p53 as an Antigen in Cancer Immunotherapy. International journal of molecular sciences 21 (11) (2020)
Navid Sobhani, Silvia P Corona, Giandomenico Roviello, Stefan Bagby, Alberto D'Angelo, Giandomenico Iezzi, Daniele Generali
Immune-gene signature: a new tool for patient selection for checkpoint inhibitors? Future oncology (London, England) 16 (19) (2020)
Alberto D'Angelo, Navid Sobhani, Robert Chapman, Stefan Bagby, Carlotta Bortoletti, Mirko Traversini, Katia Ferrari, Luca Voltolini, Jacob Darlow, Giandomenico Roviello
Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies. Cancers 12 (11) (2020)
Alberto D'Angelo, Stefan Bagby, Ilaria Camilla Galli, Carlotta Bortoletti, Giandomenico Roviello
Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand. Expert review of clinical pharmacology 13 (10) (2020)
Alberto D'Angelo, Navid Sobhani, Giandomenico Roviello, Stefan Bagby, Deborah Bonazza, Cristina Bottin, Fabiola Giudici, Fabrizio Zanconati, Nicolo De Manzini, Alessandra Guglielmi, Daniele Generali
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma. PloS one 14 (8) (2019)

Alberto D'Angelo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alberto D'Angelo